The FDA has granted approval for the ANDA of Lupin’s Sacubitril and Valsartan Tablets for heart failure patients.

Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...

Lupin has received tentative approval from the USFDA to market a generic HIV drug in the US under PEPFAR. The drug, made at ...

Today’s stock recommendations feature a mix of picks from the pharmaceutical, insurance, and chemicals sectors.

Lupin receives US FDA approval for sacubitril and valsartan tablets: Our Bureau, Mumbai Friday, January 24, 2025, 15:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) announc ...

Lupin receives US FDA marketing nod for generic Triumeq PD tablets for oral suspension to trteat HIV-1 infection: Our Bureau, Mumbai Friday, January 24, 2025, 14:15 Hrs [IST] Glob ...

The US healthcare system under Trump 2.0 are likely to benefit Indian players, except for the push for increased US drug ...

Mirroring the Sensex, NSE Nifty50 also ended lower by 113.15 points or 0.49 per cent at 23,092.20. The Nifty50 recorded a day ...

Announcements on cancer treatment are important, data shows. Data by Previu Health - a startup working in screening and prevention of cancer – shows that with 1 in 9 Indians at risk of cancer and ...

Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 97,595.41 Crore) operating in Pharmaceuticals sector. Lupin Ltd. key Products/Revenue Segments include ...

Drug firm Lupin on Friday said it has received approval from the US health regulator to market a generic HIV medication in ...